首页> 外文OA文献 >The use of antiestrogens tamoxifen and nafoxidine in the treatment of human breast cancer in correlation with estrogen receptor values.A phase II study

【2h】

The use of antiestrogens tamoxifen and nafoxidine in the treatment of human breast cancer in correlation with estrogen receptor values.A phase II study

机译：抗雌激素制革毒素和萘昔芬的用途在雌激素受体值相关的治疗中治疗人乳腺癌。II期研究

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

著录项
引文网络
相似文献
相关主题

著录项

作者
Dane L. Moseson; Gordon H. Sasaki; William G. Kraybill; Benjamin S. Leung; Charlene E. Davenport; William S. Fletcher;
展开▼
作者单位

展开▼
年度 1978
总页数
原文格式 PDF
正文语种
中图分类

相似文献

外文文献
中文文献
专利

1. Postoperative chemo-endocrine treatment with mitomycin C, tamoxifen, and UFT is effective for patients with premenopausal estrogen receptor-positive stage II breast cancer. Nishinihon Cooperative Study Group of Adjuvant Therapy for Breast Cancer. [J] . Sugimachi K, Maehara Y, Akazawa K, Breast cancer research and treatment. . 1999,第2期

机译：丝裂霉素C，他莫昔芬和UFT的术后化学内分泌治疗对绝经前雌激素受体阳性的II期乳腺癌患者有效。 Nishinihon乳腺癌辅助治疗合作研究组。
2. Canadian Cancer Trials Group IND197: a phase II study of foretinib in patients with estrogen receptor, progesterone receptor, and human epidermal growth factor receptor 2-negative recurrent or metastatic breast cancer [J] . Rayson Daniel, Lupichuk Sasha, Potvin Kylea, Breast cancer research and treatment. . 2016,第1期

机译：加拿大癌症试验小组IND197：Foretinib在雌激素受体，孕激素受体和人表皮生长因子受体2阴性的复发性或转移性乳腺癌患者中进行的II期研究
3. Phase III study comparing exemestane with tamoxifen as first-line hormonal treatment of metastatic breast cancer in postmenopausal women: the European Organisation for Research and Treatment of Cancer Breast Cancer Cooperative Group. [J] . Paridaens RJ, Dirix LY, Beex LV, Journal of Clinical Oncology . 2008,第30期

机译：III期研究比较依西美坦与他莫昔芬作为绝经后妇女转移性乳腺癌的一线激素治疗：欧洲乳腺癌研究与治疗合作组织。
4. Study on Molecular Docking of Red Betel (Piper Crocatum Ruiz Pav.) Active Compound and Tamoxifen Drug as an Inhibitor of Estrogen Receptor-α (ER-α) that Plays a Role in Breast Cancer [C] . Siti Imroatul Maslikah, Sri Rahayu Lestari, Nursasi Handayani, International Conference on Life Sciences and Technology . 2020

机译：红色槟榔（吹笛茶叶ruiz＆pav.）活性化合物和三氧化物药物作为发挥乳腺癌作用的雌激素受体-α（ER-α）抑制剂的研究
5. Gene regulation by estrogen and tamoxifen in estrogen-receptor positive and estrogen-receptor negative human breast cancer cells: Characterization and quantification by real-time PCR. [D] . Yuan, Xia. 2004

机译：雌激素受体阳性和雌激素受体阴性人类乳腺癌细胞中雌激素和他莫昔芬的基因调控：实时PCR的表征和定量。
6. Phase III Study Comparing Exemestane With Tamoxifen As First-Line Hormonal Treatment of Metastatic Breast Cancer in Postmenopausal Women: The European Organisation for Research and Treatment of Cancer Breast Cancer Cooperative Group [O] . Robert J. Paridaens, Luc Y. Dirix, Louk V. Beex, -1

机译：依西美坦与他莫昔芬作为绝经后妇女转移性乳腺癌的一线激素治疗的三阶段研究：欧洲乳腺癌研究与治疗合作组织
7. A randomized phase II presurgical trial of weekly low-dose tamoxifen versus raloxifene versus placebo in premenopausal women with estrogen receptor-positive breast cancer [O] . Davide Serrano, Matteo Lazzeroni, Sara Gandini, 2013

机译：每周低剂量他莫昔芬与雷洛昔芬对安慰剂治疗女性绝经前妇女雌激素受体阳性乳腺癌的随机II期临床前试验

The use of antiestrogens tamoxifen and nafoxidine in the treatment of human breast cancer in correlation with estrogen receptor values.A phase II study

著录项

引文网络

相似文献

相关主题

期刊订阅